ロード中...
Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide()
We report a coronavirus disease 2019 (COVID-19) case with rheumatoid arthritis taking iguratimod. The patient who continued iguratimod therapy without dose reduction was treated with ciclesonide had an uneventful clinical course, but prolonged detection of severe acute respiratory syndrome coronavir...
保存先:
| 出版年: | J Infect Chemother |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7328613/ https://ncbi.nlm.nih.gov/pubmed/32631736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2020.06.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|